nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—CYP2D6—Niacin—atherosclerosis	0.238	0.3	CbGbCtD
Alprenolol—CYP2D6—Simvastatin—atherosclerosis	0.188	0.237	CbGbCtD
Alprenolol—CYP2D6—Pravastatin—atherosclerosis	0.184	0.232	CbGbCtD
Alprenolol—CYP2D6—Lovastatin—atherosclerosis	0.184	0.232	CbGbCtD
Alprenolol—ADRB3—Signaling Pathways—SPP1—atherosclerosis	9.82e-05	0.000478	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	9.82e-05	0.000477	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	9.81e-05	0.000477	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	9.8e-05	0.000477	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL8—atherosclerosis	9.78e-05	0.000475	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	9.75e-05	0.000474	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	9.73e-05	0.000473	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	9.69e-05	0.000471	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VWF—atherosclerosis	9.65e-05	0.000469	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	9.6e-05	0.000467	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOC3—atherosclerosis	9.59e-05	0.000466	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LDLR—atherosclerosis	9.53e-05	0.000463	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	9.52e-05	0.000463	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	9.39e-05	0.000457	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	9.32e-05	0.000453	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL3—atherosclerosis	9.31e-05	0.000453	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—FABP4—atherosclerosis	9.23e-05	0.000449	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LCAT—atherosclerosis	9.23e-05	0.000449	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	9.12e-05	0.000443	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PDGFB—atherosclerosis	9.09e-05	0.000442	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	9.07e-05	0.000441	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA4—atherosclerosis	9.06e-05	0.00044	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	8.91e-05	0.000433	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NCF1—atherosclerosis	8.91e-05	0.000433	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	8.9e-05	0.000433	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	8.87e-05	0.000431	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AGT—atherosclerosis	8.87e-05	0.000431	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	8.8e-05	0.000428	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	8.8e-05	0.000428	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	8.76e-05	0.000426	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	8.72e-05	0.000424	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LEP—atherosclerosis	8.69e-05	0.000423	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—atherosclerosis	8.69e-05	0.000423	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	8.68e-05	0.000422	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—F2—atherosclerosis	8.67e-05	0.000422	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CAV1—atherosclerosis	8.61e-05	0.000419	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	8.61e-05	0.000419	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	8.61e-05	0.000419	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOA1—atherosclerosis	8.59e-05	0.000418	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	8.58e-05	0.000417	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	8.58e-05	0.000417	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	8.58e-05	0.000417	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	8.57e-05	0.000417	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AGT—atherosclerosis	8.53e-05	0.000415	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	8.49e-05	0.000413	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	8.42e-05	0.000409	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR2—atherosclerosis	8.42e-05	0.000409	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	8.39e-05	0.000408	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	8.39e-05	0.000408	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	8.39e-05	0.000408	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CYBA—atherosclerosis	8.38e-05	0.000408	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	8.3e-05	0.000404	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ESR1—atherosclerosis	8.3e-05	0.000404	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	8.24e-05	0.000401	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	8.22e-05	0.0004	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PARP1—atherosclerosis	8.2e-05	0.000399	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLAT—atherosclerosis	8.2e-05	0.000399	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHRL—atherosclerosis	8.2e-05	0.000399	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—F2—atherosclerosis	8.2e-05	0.000399	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	8.06e-05	0.000392	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	7.88e-05	0.000383	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—F2—atherosclerosis	7.88e-05	0.000383	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	7.84e-05	0.000381	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	7.8e-05	0.000379	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	7.8e-05	0.000379	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	7.8e-05	0.000379	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA2—atherosclerosis	7.8e-05	0.000379	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	7.71e-05	0.000375	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	7.7e-05	0.000375	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	7.54e-05	0.000367	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	7.53e-05	0.000366	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	7.51e-05	0.000365	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	7.48e-05	0.000364	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPA—atherosclerosis	7.44e-05	0.000362	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—atherosclerosis	7.43e-05	0.000361	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	7.36e-05	0.000358	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	7.34e-05	0.000357	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	7.32e-05	0.000356	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL2—atherosclerosis	7.31e-05	0.000355	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	7.29e-05	0.000355	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—BGN—atherosclerosis	7.2e-05	0.00035	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KNG1—atherosclerosis	7.2e-05	0.00035	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1—atherosclerosis	7.18e-05	0.000349	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	7.18e-05	0.000349	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	7.16e-05	0.000348	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	7.13e-05	0.000347	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA5—atherosclerosis	7.13e-05	0.000347	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	7.02e-05	0.000341	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLG—atherosclerosis	6.97e-05	0.000339	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	6.91e-05	0.000336	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	6.86e-05	0.000334	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	6.82e-05	0.000332	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	6.75e-05	0.000328	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	6.67e-05	0.000324	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	6.64e-05	0.000323	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	6.63e-05	0.000322	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	6.6e-05	0.000321	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	6.52e-05	0.000317	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—atherosclerosis	6.51e-05	0.000317	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	6.49e-05	0.000316	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	6.45e-05	0.000313	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	6.39e-05	0.000311	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP3—atherosclerosis	6.38e-05	0.00031	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—atherosclerosis	6.35e-05	0.000309	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	6.34e-05	0.000308	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	6.31e-05	0.000307	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	6.29e-05	0.000306	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	6.25e-05	0.000304	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	6.21e-05	0.000302	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOB—atherosclerosis	6.17e-05	0.0003	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	6.16e-05	0.000299	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	6.15e-05	0.000299	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	6.11e-05	0.000297	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EDN1—atherosclerosis	6.07e-05	0.000295	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	6.02e-05	0.000293	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL5—atherosclerosis	6.02e-05	0.000293	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	5.98e-05	0.000291	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	5.95e-05	0.000289	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LIPC—atherosclerosis	5.91e-05	0.000287	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LPL—atherosclerosis	5.89e-05	0.000286	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOC3—atherosclerosis	5.87e-05	0.000286	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	5.85e-05	0.000285	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LDLR—atherosclerosis	5.84e-05	0.000284	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	5.83e-05	0.000283	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	5.8e-05	0.000282	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	5.78e-05	0.000281	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	5.72e-05	0.000278	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	5.7e-05	0.000277	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CETP—atherosclerosis	5.7e-05	0.000277	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	5.68e-05	0.000276	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	5.58e-05	0.000271	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SPP1—atherosclerosis	5.58e-05	0.000271	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	5.55e-05	0.00027	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—atherosclerosis	5.49e-05	0.000267	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	5.46e-05	0.000265	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	5.39e-05	0.000262	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	5.28e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	5.27e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—atherosclerosis	5.22e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	5.17e-05	0.000251	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	5.16e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	5.16e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	5.16e-05	0.000251	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	5.16e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	5.15e-05	0.00025	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	5.11e-05	0.000249	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	5.1e-05	0.000248	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	5.08e-05	0.000247	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	5.07e-05	0.000246	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	5.05e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	5.05e-05	0.000245	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AGT—atherosclerosis	5.04e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	5e-05	0.000243	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	4.99e-05	0.000243	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—atherosclerosis	4.93e-05	0.00024	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—atherosclerosis	4.93e-05	0.00024	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	4.93e-05	0.00024	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CAV1—atherosclerosis	4.89e-05	0.000238	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—atherosclerosis	4.88e-05	0.000237	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—F2—atherosclerosis	4.87e-05	0.000237	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	4.82e-05	0.000234	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—F2—atherosclerosis	4.76e-05	0.000231	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ESR1—atherosclerosis	4.71e-05	0.000229	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	4.69e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	4.66e-05	0.000226	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—F2—atherosclerosis	4.65e-05	0.000226	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—atherosclerosis	4.65e-05	0.000226	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.6e-05	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	4.55e-05	0.000221	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	4.46e-05	0.000217	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	4.45e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	4.44e-05	0.000216	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—atherosclerosis	4.41e-05	0.000214	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	4.36e-05	0.000212	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	4.34e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—atherosclerosis	4.31e-05	0.00021	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	4.31e-05	0.000209	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	4.27e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	4.26e-05	0.000207	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	4.24e-05	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—atherosclerosis	4.22e-05	0.000205	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	4.17e-05	0.000203	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—atherosclerosis	4.15e-05	0.000202	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—atherosclerosis	4.08e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	4.05e-05	0.000197	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	3.96e-05	0.000193	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	3.94e-05	0.000192	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	3.87e-05	0.000188	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	3.86e-05	0.000188	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	3.78e-05	0.000184	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOB—atherosclerosis	3.78e-05	0.000184	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—atherosclerosis	3.7e-05	0.00018	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.67e-05	0.000179	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPL—atherosclerosis	3.61e-05	0.000175	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX1—atherosclerosis	3.52e-05	0.000171	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	3.43e-05	0.000167	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CD36—atherosclerosis	3.43e-05	0.000167	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	3.35e-05	0.000163	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	3.31e-05	0.000161	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	3.28e-05	0.000159	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	3.26e-05	0.000159	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	3.25e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—atherosclerosis	3.24e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	3.24e-05	0.000158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	3.19e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARA—atherosclerosis	3.19e-05	0.000155	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	3.17e-05	0.000154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—atherosclerosis	3.12e-05	0.000152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	3.1e-05	0.000151	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AGT—atherosclerosis	3.08e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	3.07e-05	0.000149	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	3.03e-05	0.000148	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—atherosclerosis	3.02e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	3.02e-05	0.000147	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	3.01e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	3e-05	0.000146	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAV1—atherosclerosis	2.99e-05	0.000146	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—atherosclerosis	2.99e-05	0.000146	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—atherosclerosis	2.99e-05	0.000145	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.97e-05	0.000144	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	2.95e-05	0.000143	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	2.94e-05	0.000143	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.93e-05	0.000143	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.88e-05	0.00014	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.88e-05	0.00014	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	2.78e-05	0.000135	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	2.76e-05	0.000134	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.73e-05	0.000133	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	2.72e-05	0.000132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	2.7e-05	0.000131	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.66e-05	0.00013	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.64e-05	0.000128	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	2.63e-05	0.000128	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—atherosclerosis	2.63e-05	0.000128	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—atherosclerosis	2.58e-05	0.000126	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	2.58e-05	0.000125	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	2.56e-05	0.000124	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.52e-05	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	2.5e-05	0.000122	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.44e-05	0.000119	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—atherosclerosis	2.37e-05	0.000115	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—atherosclerosis	2.26e-05	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.07e-05	0.000101	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	1.93e-05	9.37e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	1.88e-05	9.16e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.84e-05	8.96e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.78e-05	8.64e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.74e-05	8.45e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.7e-05	8.26e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—atherosclerosis	1.04e-05	5.06e-05	CbGpPWpGaD
